|Day Low/High||119.35 / 120.93|
|52 Wk Low/High||82.95 / 128.54|
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Amgen, Gilead, and Celgene.
Stephanie Link, director of research at TheStreet, eliminated her position in Abbott to build a position in Bristol Meyers.
Here's some of what we can look forward to on Wednesday. It's always an honor to fill in for Doug! Thanks for spending the day with me. Tomorrow, Fed Chairman Ben Bernanke appears before the House. His statement will likely be a replay of today's, b...
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Abbott Laboratories, ConocoPhillips, and Facebook.
Latch on to this rising trend with these names, which achieved top marks with my stock strategies.
Intel is attracting institutional buyers, and it always pays to follow that crowd.
I've finally picked up some Abbott Labs stock, which has been slowly breaking out of a base.
Oliver Pursche, portfolio manager for the GMG Defensive Beta fund, names his favorite high dividend paying stocks including McDonald's, Intel and Abbott Labs.
The pediatric nutrition company leads the industry, and demand remains firm despite economic slowdowns.
You can use this opportunity to join the move toward stocks that have little European exposure.
The healthcare sector did well as a whole Monday, so let's go over some individual names.
There's more drama in Europe and a slew of high-profile earnings reports in the U.S. this morning.
German economic data, Japan downgrade, news from Libya send stock futures lower.
My survey may not be scientific, but the results speak for themselves.